Gossamer Bio, Inc. (GOSS) Financials

$1.40

south_east
-$0.13 (-8.5%)
Day's range
$1.4
Day's range
$1.54
$0$0-$50M-$50M-$100M-$100M-$150M-$150M-$200M-$200M-$250M-$250M-$300M-$300MEarning201720172018201820192019202020202021202120222022202320236%6%5%5%4%4%3%3%2%2%1%1%0%0%Profit Margin
Profit Margin
Revenue
Earnings

GOSS Income statement / Annual

Last year (2023), Gossamer Bio, Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2023, Gossamer Bio, Inc.'s net income was -$179.82 M. See Gossamer Bio, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $4.39 M $4.43 M $5.17 M $4.27 M $3.09 M $297,000.00 $0.00 $0.00
Gross Profit -$4.39 M -$4.43 M -$5.17 M -$4.27 M -$3.09 M -$297,000.00 $0.00 $0.00
Gross Profit Ratio 0 0 0 0 0 0 0 0
Research and Development Expenses $145.30 M $170.92 M $170.27 M $160.85 M $143.40 M $55.28 M $891,000.00 $0.00
General & Administrative Expenses $38.46 M $47.61 M $45.78 M $49.73 M $39.14 M $44.05 M $262,000.00 $83,000.00
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $38.46 M $47.61 M $45.78 M $49.73 M $39.14 M $44.05 M $262,000.00 $83,000.00
Other Expenses $0.00 $1.51 M $799,000.00 -$174,000.00 $5.83 M $316,000.00 $0.00 $0.00
Operating Expenses $183.76 M $218.53 M $216.05 M $210.58 M $182.54 M $99.33 M $1.15 M $83,000.00
Cost And Expenses $183.76 M $218.53 M $216.05 M $210.58 M $182.54 M $99.33 M $1.15 M $83,000.00
Interest Income $2.00 M $1.58 M $761,000.00 $3.44 M $3,625.00 $1.72 M $0.00 $0.00
Interest Expense $13.51 M $13.88 M $19.44 M $12.67 M $0.00 $12,000.00 $118,000.00 $0.00
Depreciation & Amortization $1.61 M $4.43 M $5.17 M $4.27 M $3.09 M $297,000.00 $1.15 M $83,000.00
EBITDA -$172.15 M -$211.07 M -$209.32 M -$233.96 M -$186.14 M -$148.99 M -$6.65 M -$83,000.00
EBITDA Ratio 0 0 0 0 0 0 0 0
Operating Income Ratio 0 0 0 0 0 0 0 0
Total Other Income/Expenses Net $3.94 M -$10.79 M -$17.88 M -$9.40 M $5.83 M $2.02 M -$118,000.00 $0.00
Income Before Tax -$179.82 M -$229.38 M -$234.00 M -$243.36 M -$180.31 M -$146.97 M -$6.77 M -$83,000.00
Income Before Tax Ratio 0 0 0 0 0 0 0 0
Income Tax Expense $0.00 $10.85 M $15.07 M $8.22 M $511,000.00 $2.04 M -$5.38 M -$83,000.00
Net Income -$179.82 M -$240.23 M -$249.08 M -$251.58 M -$180.82 M -$146.97 M -$6.77 M -$83,000.00
Net Income Ratio 0 0 0 0 0 0 0 0
EPS -1.18 -2.84 -3.33 -3.67 -3.3 -2.43 -0.27 -0.0033
EPS Diluted -1.18 -2.84 -3.33 -3.67 -3.3 -2.43 -0.27 -0.0033
Weighted Average Shares Out $152.62 M $84.57 M $74.84 M $68.51 M $54.74 M $60.40 M $24.83 M $24.83 M
Weighted Average Shares Out Diluted $152.62 M $84.57 M $74.84 M $68.51 M $54.74 M $60.40 M $24.83 M $24.83 M
Link